FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefotaxime Sodium (Claforan) Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Sanofi-Aventis (Revised 03/09/2017)

Company Contact Information:
800-981-2491

Presentation Posting Date Related Information
500mg Single Dose Glass Fliptop Vial (NDC 0039-0017-10) N/A Discontinuation of the manufacture of the drug
1g Single Dose Glass Fliptop Vial (NDC 0039-0018-10) N/A Discontinuation of the manufacture of the drug
2g Single Dose Glass Fliptop Vial (NDC 0039-0019-10) N/A Discontinuation of the manufacture of the drug
10g Pharmacy Bulk Package Glass Fliptop Vial (NDC 0039-0020-01) N/A Discontinuation of the manufacture of the drug
1g Single Dose ADD-Vantage™ Glass Vial (NDC 0039-0023-25) N/A Discontinuation of the manufacture of the drug
2g Single Dose ADD-Vantage™ Glass Vial (NDC 0039-0024-25) N/A Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English